Masoud Nouri-Vaskeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Masoud Nouri-Vaskeh has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Leila Alizadeh
Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
6 shared publications - Aida Malek Mahdavi
Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
3 shared publications - Akbar Sharifi
Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publications Mohammad Zarei
Departrment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, USA
3 shared publicationsAkbar Sharifi
2 shared publications- Alireza Khabbazi
Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications
Latest Publications
- Open Access
- 21 October 2024
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
Investigation of the diagnostic value of neutrophil-to-lymphocyte ratio for evaluating the severity of pancreatitis in patients with acute pancreatitis
Background. Acute pancreatitis (AP) is considered a gastrointestinal disorder that may lead to a systemic inflammatory response and requires urgent hospitalization. Currently, the bedside index of severity in acute pancreatitis (BISAP) scoring system is used to estimate the severity of the disease. This study sought to investigate the significant relationship between the infectious inflammatory components of the neutrophil-to-lymphocyte ratio (NLR), which can only be obtained by a simple blood test. Then, this ratio was compared with the BISAP scoring system. Methods. This cohort study was conducted at Imam Reza Hospital of Tabriz University of Medical Sciences in 2017‒2018. A total of 98 hospitalized patients with our desired criteria were included in the study. A complete blood count differential was obtained, and the BISAP score was calculated and analyzed, along with demographic data. Results. The NLR and the age of patients had a significant relationship with the BISAP variable (P < 0.05). For one unit (year) increase in patients’ age, the chance of being placed in the higher categories of the BISAP score increased by 1.14 and 1.09 times, respectively. Gender, smoking, and underlying diseases had no significant relationship with the BISAP score (P > 0.05). Conclusion. The initial values of the NLR can be used to determine the prognosis and severity of the disease in patients with acute pancreatitis in a quick, easy, and accessible way. Practical Implications. Simple ratios such as NLR can be utilized to perform immediate measurements for the management of acute pancreatitis.
- 21 October 2024
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
Open AccessInvestigation of the diagnostic value of neutrophil-to-lymphocyte ratio for evaluating the severity of pancreatitis in patients with acute pancreatitis
Background. Acute pancreatitis (AP) is considered a gastrointestinal disorder that may lead to a systemic inflammatory response and requires urgent hospitalization. Currently, the bedside index of severity in acute pancreatitis (BISAP) scoring system is used to estimate the severity of the disease. This study sought to investigate the significant relationship between the infectious inflammatory components of the neutrophil-to-lymphocyte ratio (NLR), which can only be obtained by a simple blood test. Then, this ratio was compared with the BISAP scoring system. Methods. This cohort study was conducted at Imam Reza Hospital of Tabriz University of Medical Sciences in 2017‒2018. A total of 98 hospitalized patients with our desired criteria were included in the study. A complete blood count differential was obtained, and the BISAP score was calculated and analyzed, along with demographic data. Results. The NLR and the age of patients had a significant relationship with the BISAP variable (P < 0.05). For one unit (year) increase in patients’ age, the chance of being placed in the higher categories of the BISAP score increased by 1.14 and 1.09 times, respectively. Gender, smoking, and underlying diseases had no significant relationship with the BISAP score (P > 0.05). Conclusion. The initial values of the NLR can be used to determine the prognosis and severity of the disease in patients with acute pancreatitis in a quick, easy, and accessible way. Practical Implications. Simple ratios such as NLR can be utilized to perform immediate measurements for the management of acute pancreatitis.
- Open Access
- 17 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 1046
Biomarkers for Transient Ischemic Attack: A Brief Perspective of Current Reports and Future Horizons
Cerebrovascular disease is the leading cause of long-term disability in the world and the third-leading cause of death in the United States. The early diagnosis of transient ischemic attack (TIA) is of great importance for reducing the mortality and morbidity of cerebrovascular diseases. Patients with TIA have a high risk of early subsequent ischemic stroke and the development of permanent nervous system lesions. The diagnosis of TIA remains a clinical diagnosis that highly relies on the patient’s medical history assessment. There is a growing list of biomarkers associated with different components of the ischemic cascade in the brain. In this review, we take a closer look at the biomarkers of TIA and their validity with a focus on the more clinically important ones using recent evidence of their reliability for practical usage.
- 17 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 1046
Open AccessBiomarkers for Transient Ischemic Attack: A Brief Perspective of Current Reports and Future Horizons
Cerebrovascular disease is the leading cause of long-term disability in the world and the third-leading cause of death in the United States. The early diagnosis of transient ischemic attack (TIA) is of great importance for reducing the mortality and morbidity of cerebrovascular diseases. Patients with TIA have a high risk of early subsequent ischemic stroke and the development of permanent nervous system lesions. The diagnosis of TIA remains a clinical diagnosis that highly relies on the patient’s medical history assessment. There is a growing list of biomarkers associated with different components of the ischemic cascade in the brain. In this review, we take a closer look at the biomarkers of TIA and their validity with a focus on the more clinically important ones using recent evidence of their reliability for practical usage.
- Open Access
- 10 October 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (10) , e04945
Trichorrhexis invaginata and ichthyosiform erythroderma in netherton syndrome
Trichorrhexis invaginata and ichthyosiform erythroderma are pathognomic for Netherton Syndrome.
- 10 October 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (10) , e04945
Open AccessTrichorrhexis invaginata and ichthyosiform erythroderma in netherton syndrome
Trichorrhexis invaginata and ichthyosiform erythroderma are pathognomic for Netherton Syndrome.
- 12 April 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (1) , 1-8
Comparison of spirometry and impulse oscillometry in methacholine challenge test for the detection of airway hyperresponsiveness in adults
Airway hyper-responsiveness (AHR) is a characteristic feature of asthma. The aim of this study was to compare the impulse oscillometry (IOS) and spirometry to methacholine for AHR detection among individuals with clinically hyper-reactive airway disease suggestive of bronchial asthma and baseline spirometry were normal. Adults with symptoms suggestive of AHR and normal baseline spirometry test were selected. The short protocol of methacholine challenge test (MCT) was performed for all subjects using IOS and spirometry simultaneously. The primary endpoint was to compare the methacholine dosage causing a 20% drop in forced expiratory volume in one second (FEV1), with methacholine dosage that causing 40% increasing the baseline respiratory resistance at 5 hertz (R5), as measured by IOS. A total of 235 participants were analyzed, 184 (78.2%) had positive test results with R5, while 81 (34.4%) had positive MCT results with FEV1.The sensitivity and specificity of MCT with R5were 87.3%, 64.6%, and MCT with FEV1 were 39.1%, 85.4%, respectively. The area under the receiver operating characteristic (ROC) curve was greater at lower doses of MCT at R5, (AUROC: 0.653; p= 0.01). The results showed higher sensitivity, negative predictive value, and earlier response of the short protocol of MCT with IOS, compared to MCT with spirometry. Our study suggested the utility of IOS in addition to conventional spirometry as a method of choice in MCT for detection of AHR.
- 12 April 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (1) , 1-8
Comparison of spirometry and impulse oscillometry in methacholine challenge test for the detection of airway hyperresponsiveness in adults
Airway hyper-responsiveness (AHR) is a characteristic feature of asthma. The aim of this study was to compare the impulse oscillometry (IOS) and spirometry to methacholine for AHR detection among individuals with clinically hyper-reactive airway disease suggestive of bronchial asthma and baseline spirometry were normal. Adults with symptoms suggestive of AHR and normal baseline spirometry test were selected. The short protocol of methacholine challenge test (MCT) was performed for all subjects using IOS and spirometry simultaneously. The primary endpoint was to compare the methacholine dosage causing a 20% drop in forced expiratory volume in one second (FEV1), with methacholine dosage that causing 40% increasing the baseline respiratory resistance at 5 hertz (R5), as measured by IOS. A total of 235 participants were analyzed, 184 (78.2%) had positive test results with R5, while 81 (34.4%) had positive MCT results with FEV1.The sensitivity and specificity of MCT with R5were 87.3%, 64.6%, and MCT with FEV1 were 39.1%, 85.4%, respectively. The area under the receiver operating characteristic (ROC) curve was greater at lower doses of MCT at R5, (AUROC: 0.653; p= 0.01). The results showed higher sensitivity, negative predictive value, and earlier response of the short protocol of MCT with IOS, compared to MCT with spirometry. Our study suggested the utility of IOS in addition to conventional spirometry as a method of choice in MCT for detection of AHR.
- 12 February 2021
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (8) , 5564-5581
GDF‐15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme
Glioblastoma multiforme (GBM) is the commonest primary malignant brain tumor and has a remarkably weak prognosis. According to the aggressive form of GBM, understanding the accurate molecular mechanism associated with GBM pathogenesis is essential. Growth differentiation factor 15 (GDF‐15) belongs to transforming growth factor‐β superfamily with important roles to control biological processes. It affects cancer growth and progression, drug resistance, and metastasis. It also can promote stemness in many cancers, and also can stress reactions control, bone generation, hematopoietic growth, adipose tissue performance, and body growth, and contributes to cardiovascular disorders. The role GDF‐15 to develop and progress cancer is complicated and remains unclear. GDF‐15 possesses tumor suppressor properties, as well as an oncogenic effect. GDF‐15 antitumorigenic and protumorigenic impacts on tumor development are linked to the cancer type and stage. However, the GDF‐15 signaling and mechanism have not yet been completely identified because of no recognized cognate receptor.
- 12 February 2021
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (8) , 5564-5581
GDF‐15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme
Glioblastoma multiforme (GBM) is the commonest primary malignant brain tumor and has a remarkably weak prognosis. According to the aggressive form of GBM, understanding the accurate molecular mechanism associated with GBM pathogenesis is essential. Growth differentiation factor 15 (GDF‐15) belongs to transforming growth factor‐β superfamily with important roles to control biological processes. It affects cancer growth and progression, drug resistance, and metastasis. It also can promote stemness in many cancers, and also can stress reactions control, bone generation, hematopoietic growth, adipose tissue performance, and body growth, and contributes to cardiovascular disorders. The role GDF‐15 to develop and progress cancer is complicated and remains unclear. GDF‐15 possesses tumor suppressor properties, as well as an oncogenic effect. GDF‐15 antitumorigenic and protumorigenic impacts on tumor development are linked to the cancer type and stage. However, the GDF‐15 signaling and mechanism have not yet been completely identified because of no recognized cognate receptor.
- Open Access
- 9 January 2021
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 9 (1) , e00705
Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e., chloroquine, lopinavir/ritonavir, ribavirin, tocilizumab, and remdesivir) and increase the risk of serious adverse reactions such as QT‐prolongation, retinopathy, increased risk of infection, and hepatotoxicity. This review focuses on summarizing DDIs for candidate medications used for COVID‐19 in order to minimize the adverse reactions.
- 9 January 2021
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 9 (1) , e00705
Open AccessDrug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e., chloroquine, lopinavir/ritonavir, ribavirin, tocilizumab, and remdesivir) and increase the risk of serious adverse reactions such as QT‐prolongation, retinopathy, increased risk of infection, and hepatotoxicity. This review focuses on summarizing DDIs for candidate medications used for COVID‐19 in order to minimize the adverse reactions.
- 25 December 2020
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 26 (4) , 386-392
Psychophysiological Characteristics of Aggression Associated with Depression before and after Successful Treatment with Sertraline: A Clinical Trial Study
Background: Depression associated with aggression can lead to violent behaviors. The present study was aimed to determine how sertraline, a standard medication for depression treatment, can efficiently decrease aggression and affect psychophysiological parameters in patients with depression. Methods: Patients with depression and aggression were included in a six-week trial with sertraline (50 100 mg/day). Depression diagnosis was confirmed by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Text Revision (DSM-IV-TR). Depression severity before and after treatment was assessed using Beck Depression Inventory (BDI). Aggression was evaluated by Spielberger’s State-Trait Anger Expression Inventory-2 (STAXIII). The BDI and STAXI-II were finally applied to evaluate the effectiveness of treatment. For each patient, peripheral and central psychophysiological parameters were recorded using peripheral biofeedback apparatus and electroencephalogram in the initial and final stages of treatment. These recordings were attempted to assess variations of the autonomic nervous system and electrocortical activity in response to treatment. Results: Depressive and aggressive symptoms decreased significantly over the six-week treatment period, as measured by BDI and STAXI-II. Significant changes in some of the peripheral and central psychophysiological variables were observed. Sensorimotor rhythm (SMR)/theta ratio (p=0.01) have decreased during a task, delta (p=0.02) and theta (p=0.008) wave activity and theta/alpha ratio (p=0.01) have increased during task, and theta/beta ratio has increased during both rest and task (p=0.02 for both). Among peripheral psychophysiological variables, skin conductance during task decreased significantly (p=0.03). Conclusion: Several numbers of psychophysiological parameters were influenced significantly after successful pharmacotherapy of aggressiveness in patients with depression.
- 25 December 2020
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 26 (4) , 386-392
Psychophysiological Characteristics of Aggression Associated with Depression before and after Successful Treatment with Sertraline: A Clinical Trial Study
Background: Depression associated with aggression can lead to violent behaviors. The present study was aimed to determine how sertraline, a standard medication for depression treatment, can efficiently decrease aggression and affect psychophysiological parameters in patients with depression. Methods: Patients with depression and aggression were included in a six-week trial with sertraline (50 100 mg/day). Depression diagnosis was confirmed by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Text Revision (DSM-IV-TR). Depression severity before and after treatment was assessed using Beck Depression Inventory (BDI). Aggression was evaluated by Spielberger’s State-Trait Anger Expression Inventory-2 (STAXIII). The BDI and STAXI-II were finally applied to evaluate the effectiveness of treatment. For each patient, peripheral and central psychophysiological parameters were recorded using peripheral biofeedback apparatus and electroencephalogram in the initial and final stages of treatment. These recordings were attempted to assess variations of the autonomic nervous system and electrocortical activity in response to treatment. Results: Depressive and aggressive symptoms decreased significantly over the six-week treatment period, as measured by BDI and STAXI-II. Significant changes in some of the peripheral and central psychophysiological variables were observed. Sensorimotor rhythm (SMR)/theta ratio (p=0.01) have decreased during a task, delta (p=0.02) and theta (p=0.008) wave activity and theta/alpha ratio (p=0.01) have increased during task, and theta/beta ratio has increased during both rest and task (p=0.02 for both). Among peripheral psychophysiological variables, skin conductance during task decreased significantly (p=0.03). Conclusion: Several numbers of psychophysiological parameters were influenced significantly after successful pharmacotherapy of aggressiveness in patients with depression.
- Open Access
- 1 December 2020
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 40 (04) , 435-439
Albucasis: pioneer of the modern anorectal surgery
Albucasis is one of the world’s pioneers in surgery. In his book, “Al-Tasrif”, he described the surgical procedures and tools, as well as post-operative care in detail. He introduced colorectal surgeries in detail and used topical substances to accelerate recovery. Albucasis considered different approaches for anorectal surgeries and used them according to the complexity of the cases. Many of these methods were first invented by him and the effect of his ideas on modern surgical methods is evident. In this article, we discuss anorectal diseases treated by Albucasis using surgical procedures.
- 1 December 2020
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 40 (04) , 435-439
Open AccessAlbucasis: pioneer of the modern anorectal surgery
Albucasis is one of the world’s pioneers in surgery. In his book, “Al-Tasrif”, he described the surgical procedures and tools, as well as post-operative care in detail. He introduced colorectal surgeries in detail and used topical substances to accelerate recovery. Albucasis considered different approaches for anorectal surgeries and used them according to the complexity of the cases. Many of these methods were first invented by him and the effect of his ideas on modern surgical methods is evident. In this article, we discuss anorectal diseases treated by Albucasis using surgical procedures.
- 1 November 2020
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 198, 106217
Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism
- 1 November 2020
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 198, 106217
Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism
- 12 October 2020
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 129 (2) , 373-378
Circulating glucagon-like peptide-1 level in patients with liver cirrhosis
Glucagon-like peptide-1 (GLP-1), a gut-derived incretin hormone, plays a pivotal role in glucose-induced insulin secretion. Currently, the role of incretin hormones in the pathogenesis of cirrhosis...
- 12 October 2020
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 129 (2) , 373-378
Circulating glucagon-like peptide-1 level in patients with liver cirrhosis
Glucagon-like peptide-1 (GLP-1), a gut-derived incretin hormone, plays a pivotal role in glucose-induced insulin secretion. Currently, the role of incretin hormones in the pathogenesis of cirrhosis...